D
Sell
1/13/2025Upgraded
Pharming Group N.V. (PHAR) was upgraded to D- from E+ on 1/13/2025 due to a substantial increase in the growth index, solvency index and volatility index.
E
Sell
8/5/2024Downgrade
Pharming Group N.V. (PHAR) was downgraded to E+ from D on 8/5/2024 due to a significant decline in the efficiency index, volatility index and solvency index. The quick ratio declined from 3.28 to 2.65, and total capital declined 12.13% from $390.33M to $342.96M.
D
Sell
4/11/2024Downgrade
Pharming Group N.V. (PHAR) was downgraded to D from D+ on 4/11/2024 due to a large decline in the efficiency index, growth index and total return index. Earnings per share declined from $0.0015 to -$0.0046, and net income declined 336.77% from $1.32M to -$3.12M.
D
Sell
7/24/2023Upgraded
Pharming Group N.V. (PHAR) was upgraded to D+ from D on 7/24/2023 due to an increase in the volatility index and total return index.
D
Sell
7/5/2023Downgrade
Pharming Group N.V. (PHAR) was downgraded to D from D+ on 7/5/2023 due to a noticeable decline in the efficiency index, volatility index and solvency index. Net income declined 192.94% from $15.74M to -$14.63M, the quick ratio declined from 4.53 to 3.9, and debt to equity increased from 0.66 to 0.67.
D
Sell
10/28/2022Upgraded
Pharming Group N.V. (PHAR) was upgraded to D+ from D on 10/28/2022 due to an increase in the total return index, volatility index and valuation index.
D
Sell
10/13/2022Downgrade
Pharming Group N.V. (PHAR) was downgraded to D from D+ on 10/13/2022 due to a decline in the volatility index.
D
Sell
9/6/2022Upgraded
Pharming Group N.V. (PHAR) was upgraded to D+ from D on 9/6/2022 due to an increase in the total return index and volatility index.
D
Sell
1/3/2022Upgraded
Pharming Group N.V. (PHAR) was upgraded to D from D- on 1/3/2022 due to an increase in the solvency index and valuation index.
D
Sell
9/1/2021Upgraded
Pharming Group N.V. (PHAR) was upgraded to D- from E on 9/1/2021 due to an increase in the volatility index and valuation index.
E
Sell
6/1/2021Upgraded
Pharming Group N.V. (PHAR) was upgraded to E from E- on 6/1/2021 due to an increase in the growth index, efficiency index and total return index. Operating cash flow increased 25.32% from $17.73M to $22.22M, total revenue increased 12.66% from $53.94M to $60.77M, and total capital increased 10.53% from $312.69M to $345.62M.
E
Sell
3/23/2021None
Pharming Group N.V. (PHAR) was downgraded to E- from U on 03/23/2021.
